Health Care/Hospital

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

* Middle East's first full-scale AI adoption for national screening marks Lunit's latest milestone amid rapid expansion of global cancer screening initiatives SEOUL, South Korea, July 22, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeut...

2024-07-22 21:00 2268

QingSong Health and Globethics Announce Strategic Partnership

BEIJING, July 21, 2024 /PRNewswire/ -- QingSong Health, a leading health technology platform based inChina, has announced a strategic partnership with Globethics,en international leading organization on ethical leadership based in Geneva, Switzerland. This collaboration is set to push forward the...

2024-07-22 11:49 1438

Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors

HEIDELBERG, Germany and GEMBLOUX, Belgium and SHANGHAI, China, July 21, 2024 /PRNewswire/ -- Full-Life Technologies, a fully integrated global radiotherapeutics company, today announcedthe appointment of Ted Myles to Full-Life's Board of Directors. Mr. Myles will serve as chairman of the audit c...

2024-07-22 08:00 1277

Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration

SHENZHEN, China, July 19, 2024 /PRNewswire/ -- On July 19, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences") announced that it has received the Drug Registration Certificate approved and issued by the National Medical Products Administration (NMPA) fo...

2024-07-19 22:01 4823

111 Announces Appointment of New Auditor

SHANGHAI, July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced  the appointment o...

2024-07-19 20:45 3051

Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 18, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-07-19 07:15 2843

VARON Enters CPAP and BiPAP Machine Market with Feature-Rich "Sunny Grand" Series

SEATTLE, July 18, 2024 /PRNewswire/ -- VARON , a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line ofCPAP (continuous positive airway pressure)

2024-07-19 01:30 1344

ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development

NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting inHamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of accelerating the advancement of cell and gene therapy (CGT) developme...

2024-07-19 00:00 2235

Ubie and the American Kidney Fund Collaborate to Speed Early Diagnosis and Education for Kidney Disease

* Kidney disease kills more Americans every year than breast or prostate cancer, but 9 in 10 don't know they have the disease, leading to late diagnosis and irreversible damage * The collaboration will fine tune Ubie's Symptom Checker AI with the goal of accelerating time to diagnosis for pat...

2024-07-19 00:00 1598

Assessment of supply chain risk key to improving medicine access

A four-year research project by INSEAD and five other institutions sheds light on how understandingmedical criticality, supply chain risk and their interactions could help us better address drug shortages. FONTAINEBLEAU, France, SINGAPORE and SAN FRANCISCO, July 18, 2024 /PRNewswire/ -- Drug s...

2024-07-18 23:00 2186

Samyang Corp Showcases Specialty Ingredients at World's Largest Food Technology Expo

* Participates in the IFT 2024 International Food Technology Expo held in Chicago, USA from July 15-17 * Focuses on promoting alternative sweetener Allulose and soluble dietary fiber Resistant dextrin * Displays tasting samples and actual products incorporating specialty ingredients to a...

2024-07-18 20:30 2245

Duoning showcases its comprehensive bioprocess solutions at Interphex Korea 2024

SHANGHAI, July 18, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess solution provider, announced it has attended at Interphex Korea 2024 to showcase its total bioprocess solutions for the preparation of diverse biological products. Interphex 2024 provide...

2024-07-18 20:00 1943

Neusoft Remains No.1 in China's Healthcare Security Information System Market Share

SHENYANG, China, July 18, 2024 /PRNewswire/ -- In a recent report by IDC titled China Healthcare SecurityAdministrating System Market Shares, 2023: Deepening Application, Neusoft Corporation (Neusoft, SSE: 600718)  once again ranks first inChina's healthcare security information system market sha...

2024-07-18 14:55 1795

MicuRx Presents Innovative Antibiotic Research Results at the 7th World Bronchiectasis Conference

* MicuRx showcased the latest research progress on their pipeline products, MRX-5 and MRX-8, at the 7th World Bronchiectasis Conference * Three significant study results further support the potential of MRX-5 and MRX-8 in treating Nontuberculous Mycobacteria (NTM) lung disease and Pseudomonas...

2024-07-18 13:19 1293

Oral and Maxillofacial Reconstructive Surgery at The University of Hong Kong, Powered by Large Multimodal Model for Medicine

HONG KONG, July 17, 2024 /PRNewswire/ -- In June 2024, a surgical team led by ProfessorRichard Y. Su and Dr. Jane J. Pu from the Faculty of Dentistry at The University of Hong Kong, in collaboration with United Imaging Intelligence (UII), has achieved a groundbreaking AI-assisted oral and maxillo...

2024-07-18 00:00 1957

Increasing Possibility of Success by Expanded Antibody Repertoires with Lambda Light Chain - Immunocan Launches New Mouse Strain of Fully Human Antibody Platform: ImmuMab® HKL Mouse

BOSTON, July 17, 2024 /PRNewswire/ -- Immunocan announced the successful construction of new strain of fully human antibody platform: ImmuMab® HKL mouse. This new mouse was created by in-situ replacing the variable region of Immunoglobulin genes of mouse by its counterparts from human. With Lambd...

2024-07-17 21:50 1431

Bangkok Hospital Hat Yai Achieves GHA Accreditation, Affirming Its Position as a Premier Medical Travel Destination

PALM BEACH GARDENS, Fla., July 17, 2024 /PRNewswire/ -- Bangkok Hospital Hat Yai , a leading healthcare provider in Songkhla Province,Thailand, has recently been awarded the prestigious Accreditation for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This recognition serves as a ...

2024-07-17 18:00 1558

111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024

SHANGHAIJuly 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will partic...

2024-07-17 13:31 1428

GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities

* Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis * Including blockbuster drugs such as 'Keytruda' and 'Yervoy', GCCL offers tailored clinical trial analysis services for biosimilar development YONGIN, South Korea...

2024-07-17 10:38 1683

Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors

Full-Life Technologies seals $571.5 million agreement with SK Biopharmaceuticals to license and further develop Full-Life's 'FL-091' radiopharmaceutical compound into an innovative anti-cancer treatment for worldwide markets HEIDELBERG, Germany and SEOUL, South Korea, July 16, 2024 /PRNewswire/ ...

2024-07-17 10:00 1368
1 ... 21222324252627 ... 277